A murine pressure ulcer model for evaluating persistence and treatment of Staphylococcus aureus infection

Chronic wounds, particularly pressure ulcers, pose significant healthcare challenges, especially in the elderly population. This study presents an experimental murine model of chronically infected pressure ulcers using a single cycle of magnet-induced ischemic injury combined with infection by biolu...

Full description

Saved in:
Bibliographic Details
Main Authors: Michele Tavecchio, Silvia Fanni, Xuemin Wu, Ganna Petruk, Manoj Puthia, Artur Schmidtchen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1561732/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850262286165344256
author Michele Tavecchio
Silvia Fanni
Xuemin Wu
Ganna Petruk
Manoj Puthia
Artur Schmidtchen
Artur Schmidtchen
author_facet Michele Tavecchio
Silvia Fanni
Xuemin Wu
Ganna Petruk
Manoj Puthia
Artur Schmidtchen
Artur Schmidtchen
author_sort Michele Tavecchio
collection DOAJ
description Chronic wounds, particularly pressure ulcers, pose significant healthcare challenges, especially in the elderly population. This study presents an experimental murine model of chronically infected pressure ulcers using a single cycle of magnet-induced ischemic injury combined with infection by bioluminescent Staphylococcus aureus. The model addresses previous limitations in studying pressure ulcer infection pathogenesis and evaluating treatment efficacy. By combining this model with in vivo imaging system (IVIS) technology, we achieved real-time, non-invasive monitoring of infection dynamics. This approach demonstrated persistent pressure ulcer wound infection and provided temporal and spatial data on infection status. To validate the model’s utility, we evaluated the antimicrobial efficacy of TCP-25, a synthetic host defense peptide, delivered in a topical gel formulation. Our findings highlight the potential of this model for investigating wound infection mechanisms, bacterial persistence, and therapeutic interventions. This innovative approach represents a significant advancement in pressure ulcer research, offering new opportunities for developing effective treatment strategies and improving patient outcomes.
format Article
id doaj-art-ec73ba1572dd46788522b9cded01966e
institution OA Journals
issn 2296-858X
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-ec73ba1572dd46788522b9cded01966e2025-08-20T01:55:12ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-04-011210.3389/fmed.2025.15617321561732A murine pressure ulcer model for evaluating persistence and treatment of Staphylococcus aureus infectionMichele Tavecchio0Silvia Fanni1Xuemin Wu2Ganna Petruk3Manoj Puthia4Artur Schmidtchen5Artur Schmidtchen6Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, SwedenDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, SwedenDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, SwedenDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, SwedenDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, SwedenDivision of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, SwedenDermatology, Skåne University Hospital, Lund, SwedenChronic wounds, particularly pressure ulcers, pose significant healthcare challenges, especially in the elderly population. This study presents an experimental murine model of chronically infected pressure ulcers using a single cycle of magnet-induced ischemic injury combined with infection by bioluminescent Staphylococcus aureus. The model addresses previous limitations in studying pressure ulcer infection pathogenesis and evaluating treatment efficacy. By combining this model with in vivo imaging system (IVIS) technology, we achieved real-time, non-invasive monitoring of infection dynamics. This approach demonstrated persistent pressure ulcer wound infection and provided temporal and spatial data on infection status. To validate the model’s utility, we evaluated the antimicrobial efficacy of TCP-25, a synthetic host defense peptide, delivered in a topical gel formulation. Our findings highlight the potential of this model for investigating wound infection mechanisms, bacterial persistence, and therapeutic interventions. This innovative approach represents a significant advancement in pressure ulcer research, offering new opportunities for developing effective treatment strategies and improving patient outcomes.https://www.frontiersin.org/articles/10.3389/fmed.2025.1561732/fullpressure ulcerStaphylococcus aureusTCP-25wound infectionbioimaging
spellingShingle Michele Tavecchio
Silvia Fanni
Xuemin Wu
Ganna Petruk
Manoj Puthia
Artur Schmidtchen
Artur Schmidtchen
A murine pressure ulcer model for evaluating persistence and treatment of Staphylococcus aureus infection
Frontiers in Medicine
pressure ulcer
Staphylococcus aureus
TCP-25
wound infection
bioimaging
title A murine pressure ulcer model for evaluating persistence and treatment of Staphylococcus aureus infection
title_full A murine pressure ulcer model for evaluating persistence and treatment of Staphylococcus aureus infection
title_fullStr A murine pressure ulcer model for evaluating persistence and treatment of Staphylococcus aureus infection
title_full_unstemmed A murine pressure ulcer model for evaluating persistence and treatment of Staphylococcus aureus infection
title_short A murine pressure ulcer model for evaluating persistence and treatment of Staphylococcus aureus infection
title_sort murine pressure ulcer model for evaluating persistence and treatment of staphylococcus aureus infection
topic pressure ulcer
Staphylococcus aureus
TCP-25
wound infection
bioimaging
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1561732/full
work_keys_str_mv AT micheletavecchio amurinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT silviafanni amurinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT xueminwu amurinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT gannapetruk amurinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT manojputhia amurinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT arturschmidtchen amurinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT arturschmidtchen amurinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT micheletavecchio murinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT silviafanni murinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT xueminwu murinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT gannapetruk murinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT manojputhia murinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT arturschmidtchen murinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection
AT arturschmidtchen murinepressureulcermodelforevaluatingpersistenceandtreatmentofstaphylococcusaureusinfection